US Surgical looks to new products for growth
This article was originally published in Clinica
US Surgical's revenue growth in 1995 was driven by suture sales, believes Morgan Stanley. While US sales grew just 2.2% to $520.6 million, the suture business rose 44% to $46 million. International suture sales also outpaced overall growth, rising 52% to $38 million, compared with an 18% increase to $501.7 million for total sales outside the US. The analysts expect US Surgical to continue to gain market share in 1996, particularly from the second largest player, Davis & Geck (American Home Products), with suture sales reaching $100 million.